Literature DB >> 19544363

Characteristics and prognosis for molecular breast cancer subtypes in Chinese women.

Jing Zhao1, Hong Liu, Meng Wang, Lin Gu, Xiaojing Guo, Feng Gu, Li Fu.   

Abstract

BACKGROUND: Breast cancer is regarded as a heterogeneous disease with four molecular subtypes. However, the clinicopathological characteristics among the different subtypes have not been studied in Chinese demographic. This study clarifies the prevalence and clinicopathological features of each subtype and investigates the independent prognosis factors in the Chinese population.
METHODS: A retrospective review of 1,820 Chinese breast cancer women were classified into different molecular subtypes based on the IHC-based definitions for ER, PR, and HER-2/neu to evaluate the clinicopathological features and prognosis.
RESULTS: Luminal A subtype was the most prevalent with the oldest median age at first full-term birth. The basal cell-like subtype was associated with early onset, higher percentage of node positivity, family history of breast cancer, increased tumor size, advanced tumor grade, higher prevalence in the premenopausal group, and the earlier age at menarche. Univariate and multivariate analysis of OS and RFS identified the basal cell-like and HER-2/neu subtypes as negative prognostic factors. A family history was an independent predictor of shorter RFS and OS in only the basal cell-like subtype.
CONCLUSIONS: The basal cell-like subtype is associated with a poor prognosis and a family history was a negative predictor in the basal cell-like subtype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19544363     DOI: 10.1002/jso.21307

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  24 in total

1.  Comprehensive profiling of biological processes reveals two major prognostic subtypes in breast cancer.

Authors:  Fei Chen; Sheng Gao; Fengliang Wang; Jingjing Ma; Min Zhang; Mingming Lv; Qian Zhou; Ziyi Fu; Cheng Lu; Hong Yin
Journal:  Tumour Biol       Date:  2015-10-07

2.  Clinicopathologic characteristics and prognosis for molecular subtypes in low-grade breast carcinoma: comparison with grade one invasive ductal carcinoma-not otherwise specified.

Authors:  Shuling Wang; Weidong Li; Ning Liu; Tongxian Zhang; Han Liu; Junjun Liu; Fen Liu; Wei Zhang; Estifanos P Gebreamlak; Yun Niu
Journal:  Med Oncol       Date:  2012-02-07       Impact factor: 3.064

3.  Trends and present treatment patterns of early breast cancer in Southwest China.

Authors:  Qiancheng Hu; Ting Luo; Ping He; Xiaorong Zhong; Tinglun Tian; Qing Lv; Xi Yan; Hong Zheng
Journal:  Pathol Oncol Res       Date:  2014-08-06       Impact factor: 3.201

4.  Role of ERRF, a novel ER-related nuclear factor, in the growth control of ER-positive human breast cancer cells.

Authors:  Dan Su; Xiaoying Fu; Songqing Fan; Xiao Wu; Xin-Xin Wang; Liya Fu; Xue-Yuan Dong; Jianping Jenny Ni; Li Fu; Zhengmao Zhu; Jin-Tang Dong
Journal:  Am J Pathol       Date:  2012-03       Impact factor: 4.307

5.  Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.

Authors:  Katie M O'Brien; Stephen R Cole; Chiu-Kit Tse; Charles M Perou; Lisa A Carey; William D Foulkes; Lynn G Dressler; Joseph Geradts; Robert C Millikan
Journal:  Clin Cancer Res       Date:  2010-12-15       Impact factor: 12.531

6.  Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2- advanced breast cancer in Chinese women.

Authors:  Binghe Xu; Huiping Li; Qingyuan Zhang; Wan Sun; Yanke Yu; Wei Li; Shusen Wang; Ning Liao; Peng Shen; Yuan Liu; Yaling Huang; Carlos Linn; Huadong Zhao; John Jiang; Diane Wang
Journal:  Cancer Chemother Pharmacol       Date:  2021-04-09       Impact factor: 3.333

7.  High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.

Authors:  Hong Zhao; Maopeng Yang; Jiaxin Zhao; Jincai Wang; Yue Zhang; Qingyuan Zhang
Journal:  Med Oncol       Date:  2013-02-01       Impact factor: 3.064

8.  Greater absolute risk for all subtypes of breast cancer in the US than Malaysia.

Authors:  Hisani N Horne; C R Beena Devi; Hyuna Sung; Tieng Swee Tang; Philip S Rosenberg; Stephen M Hewitt; Mark E Sherman; William F Anderson; Xiaohong R Yang
Journal:  Breast Cancer Res Treat       Date:  2014-12-24       Impact factor: 4.872

9.  Association between mammographic features and clinicopathological characteristics in invasive ductal carcinoma of breast cancer.

Authors:  Shan-Shan Sun; Bin Zhang; Hong-Meng Zhao; Xu-Chen Cao
Journal:  Mol Clin Oncol       Date:  2014-05-19

10.  Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China.

Authors:  Cong Xue; Xi Wang; Roujun Peng; Yanxia Shi; Tao Qin; Donggen Liu; Xiaoyu Teng; Shusen Wang; Li Zhang; Zhongyu Yuan
Journal:  Cancer Sci       Date:  2012-07-04       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.